Type 1 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 1 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-04-10Clinical Trial Update: A Study of t:Slim X2 With Control-IQ Technology [NA]
A completed clinical trial of t:Slim X2 with Control-IQ technology for Type 1 Diabetes Mellitus has results posted.
-
CLINICAL_TRIALS trial_result · 2023-04-04Clinical Trial Update: BetaFIT Study: Beta Cell Imaging After Faecal mIcrobiota Transplantation [Phase 2]
Phase 2 clinical trial investigating beta cell imaging after fecal microbiota transplantation in Type 1 Diabetes.
-
CLINICAL_TRIALS trial_result · 2023-04-03Clinical Trial Update: Wharton´s Jelly Derived Mesenchymal Stromal Cell Treatment of Adult Patients Diagnosed With Type I Diabetes [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating Wharton’s Jelly–derived mesenchymal stromal cells for adults with Type 1 diabetes; trial completed.
-
CLINICAL_TRIALS trial_result · 2023-03-27Clinical Trial Update: Intra-nasal Naloxone for Treatment of Impaired Awareness of Hypoglycemia [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating intranasal naloxone for treating impaired awareness of hypoglycemia in type 1 diabetes was terminated,…
-
CLINICAL_TRIALS trial_result · 2023-03-23Clinical Trial Update: Feasibility of a Decision Support System to Reduce Glucose Variability in Subject With T1DM [NA]
Feasibility study assessing whether a decision support system can reduce glucose variability in individuals with Type 1 Diabetes Mellitus. R…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2023-03-23Clinical Trial Update: Empagliflozin in Adolescent Diabetes [Phase 4]
Phase 4 trial of empagliflozin in adolescents with type 1 diabetes was withdrawn.
-
CLINICAL_TRIALS trial_result · 2023-03-22Clinical Trial Update: Safety of Artificial Pancreas Therapy in Preschoolers, Age 2-6 [NA]
Clinical trial update reporting safety of artificial pancreas therapy in preschoolers aged 2-6 with Type 1 diabetes; results posted.
-
CLINICAL_TRIALS trial_result · 2023-03-16Clinical Trial Update: Dapagliflozin in Type 1 Diabetes [Phase 4]
Phase 4 clinical trial update for dapagliflozin in type 1 diabetes (completed).
-
CLINICAL_TRIALS trial_result · 2023-03-16Clinical Trial Update: The Efficacy and Safety of REX-001 to Treat Ischemic Ulcers in Subjects With CLI Rutherford Category 5 and DM [Phase 3]
Phase 3 trial evaluating REX-001 for ischemic ulcers in patients with Critical Limb Ischemia (CLI) and diabetes was terminated.
-
CLINICAL_TRIALS trial_result · 2023-03-14Clinical Trial Update: Effects of Dapagliflozin on Hormonal Glucose Homeostasis in Type 1 Diabetes [Phase 3]
Phase 3 trial update examining effects of dapagliflozin on hormonal glucose homeostasis in type 1 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2023-03-14Clinical Trial Update: Safety Study and Therapeutic Effects of Umbilical Cord Blood Treg on Autoimmune Diabetes [Phase 1, Phase 2]
Phase 1/2 trial evaluating safety and potential therapeutic effects of umbilical cord blood regulatory T cells for Type 1 diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2023-03-14Clinical Trial Update: Safety and Efficacy of Umbilical Cord Blood Regulatory T Cells Plus Liraglutide on Autoimmune Diabetes [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating safety and efficacy of umbilical cord blood regulatory T cells combined with liraglutide for autoimmun…
-
CLINICAL_TRIALS trial_result · 2023-03-09Clinical Trial Update: ADvanced Hybrid Closed Loop Study in Adult Population With Type 1 Diabetes [NA]
A completed clinical trial evaluating an Advanced Hybrid Closed Loop system for adults with Type 1 Diabetes; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-03-07Clinical Trial Update: "FEXIS": (Feasibility of an Extended Wear CSII Set in Participants With T1DM) [NA]
Completed feasibility trial of an extended wear continuous subcutaneous insulin infusion set for adults with type 1 diabetes; results posted…
-
CLINICAL_TRIALS trial_result · 2023-03-02Clinical Trial Update: Effect of Liraglutide on Subclinical Atherosclerosis in Patients With Type 1 Diabetes Mellitus [Phase 3]
Phase 3 trial assessing the effect of liraglutide on subclinical atherosclerosis in patients with type 1 diabetes mellitus has completed.
-
FDA approval · 2023-02-28FDA Approved: NOVOLOG — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for NovoLog (insulin aspart) filed by Novo Nordisk.
-
FDA approval · 2023-02-28FDA Approved: INSULIN ASPART PROTAMINE AND INSULIN ASPART MIX 70/30 — Supplemental Application (Novo Nordisk Pharma, Inc.)
FDA approved a supplemental application for the insulin aspart protamine and insulin aspart mix 70/30 product (brand NovoLOG Mix 70/30) from…
-
CLINICAL_TRIALS trial_result · 2023-02-21Clinical Trial Update: A Trial to Compare the Efficacy and Safety of 2 Different Batches of Subcutaneous Dasiglucagon in Patients With T1DM [Phase 3]
A Phase 3 trial comparing two batches of subcutaneous dasiglucagon in adults with type 1 diabetes to assess efficacy and safety for hypoglyc…
-
CLINICAL_TRIALS trial_result · 2023-02-15Clinical Trial Update: Feasibility Studies of Personalized Closed Loop [NA]
Feasibility studies of a personalized closed-loop system for Type 1 Diabetes have completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-02-08Clinical Trial Update: A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 1 Diabetes [Phase 3]
Phase 3 trial comparing LY900014 to insulin lispro in adults with type 1 diabetes completed with posted results.
-
CLINICAL_TRIALS trial_result · 2023-02-06Clinical Trial Update: Study of Insulin Therapy Augmented by Real Time Sensor IN Type 1 Children and Adolescents (START-IN!) [Phase 2, Phase 3]
Clinical trial update for START-IN! evaluating insulin therapy augmented by real-time sensor data in children and adolescents with type 1 di…
-
FDA approval · 2023-02-03FDA Approved: AFREZZA — Supplemental Application (Mannkind Corporation)
The FDA approved a supplemental application for AFREZZA (insulin human) from MannKind Corporation.
-
CLINICAL_TRIALS trial_result · 2023-02-02Clinical Trial Update: Comparison of Insulin Glargine and Regular Insulin Versus NPH and Regular Insulin in the Treatment of T1DM [Phase 4]
A Phase 4 clinical trial comparing insulin glargine with regular insulin versus NPH and regular insulin for glycemic control in children wit…
-
CLINICAL_TRIALS trial_result · 2023-02-01Clinical Trial Update: A Study to Assess the Safety and Tolerability of Different Doses of AG019 Administered Alone or in Combination With Teplizumab in Participants With Recent-onset Diagnosed Type 1 Diabetes (T1D) [Phase 1, Phase 2]
A clinical trial evaluating safety and tolerability of AG019 at different doses alone or with Teplizumab in adults with recent-onset type 1 …
-
CLINICAL_TRIALS trial_result · 2023-01-23Clinical Trial Update: Combination GRA and SGLT-2i Treatment in Type 1 Diabetes [Phase 1, Phase 2]
A clinical trial update reports completion of a combination therapy with GRA and SGLT-2 inhibitor in Type 1 Diabetes across Phase 1 and Phas…